secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATOSSA THERAPEUTICS, INC. (ATOS)
CIK:        0001488039
Form:       8-K
Filed at:   2023-04-26T23:59:59+00:00
Accession:  0001437749-23-011141
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Atossa Therapeutics amends bylaws, reducing quorum from majority to one-third
-----------------------------------------------------------------------------

- Board approved amendment on April 26, 2023, effective immediately.
- Quorum for stockholder meetings reduced from majority to at least one-third of shares entitled to vote.
- New quorum applies to the 2023 Annual Meeting of Stockholders on May 4, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1488039/000143774923011141/0001437749-23-011141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1488039/000143774923011141/atos20230425_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-011141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer